Nadejda I Zoneva

Title: Nadejda I Zoneva: Innovator in Antihypoxic Drug Development

Introduction

Nadejda I Zoneva is a prominent inventor based in Sofia, Bulgaria. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypoxic drugs. Her innovative work focuses on improving treatment options for patients suffering from acute and chronic diseases.

Latest Patents

Nadejda holds a patent for an antihypoxic drug and method of its application. This drug, which exhibits verebroprotective and hepatoprotective actions, contains piracetam and orotic acid or their pharmaceutically tolerable salts in a weight ratio ranging from 500:1 to 1:2. The combined drug is administered for the treatment of various conditions, including exogenic intoxications, with daily doses varying from 0.150 to 50 g and from 0.030 to 0.30 g of both components. Clinical data confirm the synergistic effect of this combination in providing antihypoxic action. The drug can be administered both orally and parenterally, with oral therapy options including tablets, capsules, pills, solutions, and emulsions. Parenteral therapy is recommended for severe diseases and acute exogenic intoxications.

Career Highlights

Nadejda is associated with S O Pharmachim, where she continues to advance her research and development efforts. Her work has garnered attention for its potential to improve patient outcomes in critical medical situations.

Collaborations

Nadejda collaborates with notable colleagues, including Ani I Genova and Milka P Nikolova, who contribute to her research initiatives and enhance the impact of her work.

Conclusion

Nadejda I Zoneva's innovative contributions to the field of antihypoxic drugs highlight her commitment to improving healthcare solutions. Her patent reflects a significant advancement in pharmaceutical science, showcasing her role as a leading inventor in this vital area.